• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MacroGenics Inc

+ Add to Watchlist

MGNX:US

28.0400 USD 0.2800 1.01%

As of 20:10:00 ET on 11/26/2014.

Snapshot for MacroGenics Inc (MGNX)

Open: 27.8300 Day's Range: 27.5200 - 28.4900 Volume: 141,292
Previous Close: 27.7600 52wk Range: 17.3100 - 41.0000 1-Yr Rtn: +5.93%

Stock Chart for MGNX

No chart data available.
  • MGNX:US 28.0400
  • 1D
  • 1M
  • 1Y
27.7600
Interactive MGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGNX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4700
Est. EPS (USD) (12/2014) -1.1100
Est. PEG Ratio -
Market Cap (M USD) 779.37
Shares Outstanding (M) 27.79
30 Day Average Volume 249,466
Price/Book (mrq) 5.5988
Price/Sale (ttm) 5.2781
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MGNX

MacroGenics, Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Scott KoenigPresident/CEO/Co-FounderJames Karrels "Jim"CFO/VP/Secretary
Ezio BonviniSenior VP:ResearchKathryn SteinSenior VP:Product Dev
More Company Profile & Key Executives for MGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil